Either they will tell us this is normal or it’s due to “climate change.” But in reality it is neither. It has to do with sudden cardiac arrest that has been ubiquitous among young, healthy people from segments of the population that happened to have gotten a heart-inflaming gene serum beginning right around early 2021. We were hoping as the vaccines die down that the sudden deaths would abate, but now there are concerns that this is a long-term phenomenon.

The India Times reports that on Thursday, Manoj Subramanium, a perfectly health IndiGo pilot, suddenly dropped dead at the boarding gate on a scheduled flight he was to pilot from Nagpur to Pune. He was just 40 years old. According to the local hospital, the cause of death was “sudden cardiac arrest.”

The day before, another Indian pilot, who was flying off-duty from Delhi on Qatar Airways, fell ill and died in flight before the plane was diverted to Dubai. The man was just 51 years old, and according to his colleague, “He was very fit and his untimely demise has come as a big shock for everyone who knew him.” The pilot was something of a celebrity in the Indian aviation world, having spent 17 years at SpiceJet and piloted its inaugural flight in 2005.

A pair of sudden pilot deaths caused a stir in Indian media, but there is a total blackout in this part of the world. However, the blackout is even more bizarre given that a third pilot death this week occurred on a flight outbound from Miami on Monday. According to the NY Post, Iván Andaur, 56, was the pilot in the flight deck on a LATAM Airlines flight from Miami to Santiago, Chile, when several hours into the flight he went to the bathroom and collapsed in the locked stall. The crew broke into the bathroom and tried to revive Andaur after finding him unresponsive, but he was pronounced dead upon arrival in Panama after an emergency landing by his co-pilot.

This is simply not normal. The three deaths come on the heels of two non-fatal heart attacks among pilots last week. On August 9, a pilot suffered a heart attack on a United flight from Sarasota to Newark. On Aug. 7, a co-pilot for Tigerair flying from Japan to Tapai suffered a life-threatening sudden medical emergency as well. Details on both incidents are extremely thin.

This is part of a pattern of sudden cardiac arrests we’ve witnessed since 2021 and that are still continuing. Canadian cancer doctor William Makis has chronicled six more pilot deaths and 14 more incapacitations just since March.

Can we prove every single one is from the jab? Of course not. But this is not normal by any stretch of the imagination. We know that pilots are among the most jabbed population because of the ironclad mandate in most countries. They are a very healthy and constantly monitored population. As such, this sudden rash of sudden cardiac arrests is beyond suspicious at this point – on par with the “dropped suddenly” phenomenon among athletes.

It is simply astounding how pilots are not allowed to drink certain energy drinks or take common over-the-counter medications before flying, yet they were forced to take a brand-new serum whose primary mechanism of action inflames the heart to varying degrees.

A recent confidential pharmacovigilance document produced by Pfizer and posted by the European Medicines Agency showed that by July 2022, Pfizer was aware of almost 127,000 case reports of cardiac disorders, running the gamut of about 270 categories of heart damage, including many rare disorders, in addition to myocarditis. Numerous studies and surveys have found that between 7% and 13% of all recipients – depending on the dose or maker – experienced some form of chest pain, shortness of breath, or heart arrhythmia after taking the shot.

However, these problems are not limited to transient heart symptoms for a few days. A recent Swiss paper found a 1-in-35 rate of heart damage among local hospital workers with 1 in 19 presenting with elevated troponin levels, aside from 8% experiencing chest pain and 9% suffering palpitations. Also, disturbingly, 50% of those with markers for heart inflammation were not back to normal at the follow-up checkup.

The concern that subclinical myocarditis can possibly lurk around for a long period of time was further punctuated by a brand-new Italian case study of two young males who presented with myocarditis following the COVID shots. The authors found a recurrence of myocarditis with persistent lesions on the heart wall and greater levels of cardiac enzymes more than six months after it initially cleared up.

A Hong Kong study published last month in the American Heart Association’s journal Circulation found in a sample of 40 victims of vaccine-induced myocarditis with evidence of long-term heart damage 10-12 months later. The authors warn people with these long-term markers that “indicators of subclinical myocardial dysfunction and fibrosis” could induce “a long-term effect on exercise capacity and cardiac functional reserve during stress.” In other words, as we’ve been warning since 2021, it doesn’t take a rocket scientist to understand why athletes have been the canary in the heart-inflamed coal mine, given the sudden surge in adrenaline constantly experienced by those playing sports, placing them at greater risk if they suffer undetected myocarditis.

And speaking of subclinical myocarditis, here we are almost three years after the Pfizer and Moderna clinical trials, yet the companies have still not coughed up the study on subclinical myocarditis required of them by the FDA. To accommodate their friends at Pfizer, the FDA extended the deadline for the report from Dec. 31, 2022, to June 30, 2023. Well, June 30 has come and no report to speak of! Either they quietly allowed them to delay it again, or they have the data and are not releasing the report.

Oh, and wouldn’t it make sense, given Pfizer’s endless lies, to actually have an independent auditor study subclinical myocarditis? Or perhaps it will take a plane of 200 people going down while the pilot suffers a bout of Pfizercarditis before we get to the bottom of it.